Detalhe da pesquisa
1.
Multicenter, prospective, observational study of chemotherapy-induced dysgeusia in gastrointestinal cancer.
Support Care Cancer
; 30(6): 5351-5359, 2022 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-35292848
2.
[A case of gastric mixed neuroendocrine-non-neuroendocrine neoplasm that developed five years after pancreatic neuroendocrine tumor treatment].
Nihon Shokakibyo Gakkai Zasshi
; 119(3): 245-250, 2022.
Artigo
em Japonês
| MEDLINE | ID: mdl-35264488
3.
A Phase I Trial of Oxaliplatin, Irinotecan, and S-1 Combination Therapy (OX-IRIS) as Chemotherapy for Unresectable Pancreatic Cancer (HGCSG 1403).
Oncologist
; 26(10): e1675-e1682, 2021 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-34050586
4.
Impact of single-heterozygous UGT1A1 on the clinical outcomes of irinotecan monotherapy after fluoropyrimidine and platinum-based combination therapy for gastric cancer: a multicenter retrospective study.
Int J Clin Oncol
; 25(10): 1800-1806, 2020 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-32666389
5.
Study protocol of HGCSG1404 SNOW study: a phase I/II trial of combined chemotherapy of S-1, nab-paclitaxel and oxaliplatin administered biweekly to patients with advanced gastric cancer.
BMC Cancer
; 17(1): 837, 2017 12 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-29221445
6.
A case report of a recurrent abscess secondary to fish bone penetration of the ileum.
Nihon Shokakibyo Gakkai Zasshi
; 113(3): 451-6, 2016 03.
Artigo
em Japonês
| MEDLINE | ID: mdl-26947046
7.
Ramucirumab-induced Multiple Haemangiomas of the Skin: Two Case Reports.
Acta Derm Venereol
; 98(4): 454-455, 2018 Apr 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-29327066
8.
Phase II study of combined chemotherapy with irinotecan and S-1 (IRIS) plus bevacizumab in patients with inoperable recurrent or advanced colorectal cancer.
Acta Oncol
; 51(7): 867-72, 2012 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-22554343
9.
Optimal dose period for indisetron tablets for preventing chemotherapy-induced nausea and vomiting with modified FOLFOX6: a randomized pilot study.
Chemotherapy
; 58(6): 439-44, 2012.
Artigo
em Inglês
| MEDLINE | ID: mdl-23364217
10.
Study protocol for HGCSG1801: A multicenter, prospective, phase II trial of second-line FOLFIRI plus aflibercept in patients with metastatic colorectal cancer refractory to anti-EGFR antibodies.
Front Oncol
; 12: 939425, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36439491
11.
[A case of sigmoid colon cancer with temporary dysarthria associated with irinotecan].
Gan To Kagaku Ryoho
; 38(8): 1375-7, 2011 Aug.
Artigo
em Japonês
| MEDLINE | ID: mdl-21829085
12.
[A case of sigmoid colon cancer with lymphangitis carcinomatosa successfully treated with chemotherapies including molecular targeting drugs].
Gan To Kagaku Ryoho
; 37(3): 535-8, 2010 Mar.
Artigo
em Japonês
| MEDLINE | ID: mdl-20332699
13.
[Gastrointestinal ulcer, gastrointestinal perforation].
Nihon Rinsho
; 73 Suppl 2: 380-3, 2015 Feb.
Artigo
em Japonês
| MEDLINE | ID: mdl-25831787
14.
Association between the use of antibiotics and efficacy of gemcitabine plus nab-paclitaxel in advanced pancreatic cancer.
Medicine (Baltimore)
; 99(39): e22250, 2020 Sep 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-32991420
15.
Impact of tumour growth rate during preceding treatment on tumour response to regorafenib or trifluridine/tipiracil in refractory metastatic colorectal cancer.
ESMO Open
; 4(6)2019 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-32392174
16.
Comparison of efficacy and toxicity of FOLFIRINOX and gemcitabine with nab-paclitaxel in unresectable pancreatic cancer.
J Gastrointest Oncol
; 8(3): 566-571, 2017 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-28736643
17.
[Colorectal cancer chemotherapy and QOL (benefits and problems of outpatient-chemotherapy)].
Nihon Rinsho
; 69 Suppl 3: 585-8, 2011 Apr.
Artigo
em Japonês
| MEDLINE | ID: mdl-22214028
18.
Efficacy and Safety of Bolus 5-Fluorouracil and L-Leucovorin as Salvage Chemotherapy for Oral Fluoropyrimidine-Resistant Unresectable or Recurrent Gastric Cancer: A Single Center Experience.
J Gastric Cancer
; 16(3): 177-181, 2016 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-27752395